HEPZATO KIT is the only FDA approved liver-directed therapy to treat metastatic uveal melanoma
Approval includes treatment naïve and previously treated patients and is not limited by HLA genotype
Read more at prnewswire.comProvided Content: Content provided by PR Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.